Search

Search Constraints

You searched for: Author/Creator Enden, Tone

Search Results

1. "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients ‐ 30 months follow‐up": Reply. (20th July 2022)

6. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up. (20th February 2022)

7. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Issue 2 (February 2016)

8. Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism. Issue 196 (December 2020)